James E. Flynn 13D and 13G filings for Singular Genomics Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-25 9:18 pm Sale | 2025-02-21 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 1,000 100.000% | -248,495 (-99.60%) | Filing |
| 2024-12-26 8:55 pm Unchanged | 2024-12-22 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.620% | 0 (Unchanged) | Filing |
| 2024-11-01 7:54 pm Unchanged | 2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 0 (Unchanged) | Filing |
| 2024-09-12 4:07 pm Purchase | 2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC | James E. Flynn | 249,495 6.660% | 249,495 (New Position) | Filing |